T-bet-expressing B cells contribute to the autoreactive plasma cell pool in Lyn-/- mice

© 2023 The Authors. European Journal of Immunology published by Wiley-VCH GmbH..

Systemic Lupus Erythematosus (SLE) is characterized by pathogenic autoantibodies against nucleic acid-containing antigens. Understanding which B-cell subsets give rise to these autoantibodies may reveal therapeutic approaches for SLE that spare protective responses. Mice lacking the tyrosine kinase Lyn, which limits B and myeloid cell activation, develop lupus-like autoimmune diseases characterized by increased autoreactive plasma cells (PCs). We used a fate-mapping strategy to determine the contribution of T-bet+ B cells, a subset thought to be pathogenic in lupus, to the accumulation of PCs and autoantibodies in Lyn-/- mice. Approximately, 50% of splenic PCs in Lyn-/- mice originated from T-bet+ cells, a significant increase compared to WT mice. In vitro, splenic PCs derived from T-bet+ B cells secreted both IgM and IgG anti-dsDNA antibodies. To determine the role of these cells in autoantibody production in vivo, we prevented T-bet+ B cells from differentiating into PCs or class switching in Lyn-/- mice. This resulted in a partial reduction in splenic PCs and anti-dsDNA IgM and complete abrogation of anti-dsDNA IgG. Thus, T-bet+ B cells make an important contribution to the autoreactive PC pool in Lyn-/- mice.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:53

Enthalten in:

European journal of immunology - 53(2023), 8 vom: 14. Aug., Seite e2250300

Sprache:

Englisch

Beteiligte Personen:

Ottens, Kristina [VerfasserIn]
Schneider, Jalyn [VerfasserIn]
Satterthwaite, Anne B [VerfasserIn]

Links:

Volltext

Themen:

Autoantibodies
Autoantibody
EC 2.7.10.2
Immunoglobulin G
Immunoglobulin M
Journal Article
Lupus
Lyn
Lyn protein-tyrosine kinase
Plasma cell
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Src-Family Kinases
T-Box Domain Proteins
T-bet
T-box transcription factor TBX21

Anmerkungen:

Date Completed 14.08.2023

Date Revised 25.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/eji.202250300

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM356376184